Blueland pitched refillable, plastic-free cleaning products — tablets that dissolve into a reusable bottle instead of shipping another plastic spray bottle every time — on Shark Tank in 2020. Kevin O’Leary made the deal: $270,000 for 3% equity, plus a $0.50 royalty on every kit sold until his investment was paid back, at which point the royalty would step down.
Why the royalty structure, not just equity
O’Leary is known for structuring deals with royalties rather than pure equity, on the logic that royalties pay him back regardless of whether the company ever has a liquidity event (a sale or IPO) — equity is only worth something if the company eventually gets bought or goes public, but a royalty on every unit sold generates real cash from day one. For a founder, it’s a real cost on every unit sold in exchange for capital and access; for the investor, it’s a hedge against the company simply staying private and profitable forever.
What happened after the deal
Blueland’s early growth numbers were real but modest by consumer-startup standards — around $6 million in annual revenue by late 2020 — before accelerating past $10 million within a couple of years. The company raised a $20 million Series B in 2022 from Prelude Growth Partners, brought total outside funding to roughly $35 million, and crossed $100 million in lifetime sales that same year while remaining profitable, according to the company’s own disclosures at the time.
Where it stands now
Blueland has since landed placement in Target and Costco — a meaningfully bigger distribution footprint than the direct-to-consumer subscription model it launched with — and has done visible marketing collaborations, including with Kim Kardashian’s household-goods ventures. Independent trackers put the company’s valuation above $200 million as of the mid-2020s, though as with any private company, that figure is an estimate rather than an audited number.
The actual lesson in the deal
The interesting part of the Blueland story isn’t the sustainability pitch — plenty of eco-friendly consumer brands pitch on Shark Tank and don’t make it. It’s that O’Leary’s unusual royalty-plus-equity structure, which founders often resist because it taxes every sale, ended up being survivable specifically because the unit economics on refill tablets are genuinely good — cheap to manufacture and ship relative to their price. The deal structure and the product’s actual margins happened to fit each other.
